A study on thyroid, lipid profile and eGFR, protein-creatinine ratio, on assessing risk factor for renal failure

Atiya A. Inamdar; Humayun Kabir; Robert Priscilla

doi:10.53730/ijhs.v6nS7.13698

Authors

Atiya A. Inamdar Assistant Professor, Dept of Bio Chemistry, Jagannath Gupta Institute of Medical Sciences & Hospital, Kolkata, W.B. India
Humayun Kabir Consultant Physician, Dept of Medicine, Fortune Multi – Specialty Hospital, Lalbag, Murshidabad, W.B. India
Robert Priscilla
r.priscilla2010@gmail.com
Associate Professor, Dept of Microbiology, Jagannath Gupta Institute of Medical Sciences & Hospital, Kolkata, W.B. India

Keywords:

Ckd Patients, Hdl, Ldl, Creatinine, Tsh, T3 T4

Abstract

Aim: To assess the risk factors for renal dysfunction in a heterogeneous population. To determine the age and sex wise distribution of eGFR and Urinary spot Protein- Creatinine ratio (UPCR) in a heterogeneous population. To estimate the lipid profile and thyroid profile and assess their role as risk factor in renal dysfunction. Introduction: Chronic Kidney Disease (CKD), is a major health problem in India. As per the Kidney Diseases Improving Global Outcomes (KDIGO) 2012, CKD is defined¹ as abnormalities of kidney structure or function present for more than three months. Thyroid hormones were also found to influence GFR, tubular secretion and absorption.^16,17One study has shown that normal to high levels of Thyroid Stimulating Hormone (TSH) and normal to low levels of free triiodothyronine (FT3) were associated with increased risk of CKD in euthyroid subjects.¹⁸ It is also said that high level of serum free thyroxine (FT4) was associated with increased risk of CKD rather than TSH and FT3.There was also associated rapid decline in eGFR.¹⁹Many studies have found that hypothyroidism is associated with dyslipidemia and renal dysfunction.

Downloads

Download data is not yet available.

References

Levin A, Stevens PE. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014 Jan;85(1):49–61.

Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, Almeida AF, Channakeshavamurthy A, Ballal HS, Gaccione P, Issacs R. Epidemiology and risk factors of chronic kidney disease in India–results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC nephrology. 2013 Dec;14(1):114.

Coresh J, Hu J-R, Bello AK, Feldman HI, Fogo AB, Ganji MR, et al. Action plan for determining and monitoring the prevalence of chronic kidney disease. Kidney Int Suppl. 2017 Oct 1;7(2):63–70.

Raines N, González M, Wyatt C, Kurzrok M, Pool C, Lemma T, et al. Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by mesoamerican nephropathy. MEDICC Rev. 2014 Apr;16:16–22.

Hayashi K, Takayama M, Abe T, Kanda T, Hirose H, Shimizu-Hirota R, et al. Investigation of Metabolic Factors Associated with eGFR Decline Over 1 Year in a Japanese Population without CKD. J Atheroscler Thromb. 2017 Aug 1;24(8):863–75.

Adrogué HJ, Madias NE. Sodium and Potassium in the Pathogenesis of Hypertension. N Engl J Med. 2007 May 10;356(19):1966–78.

Drenjančević-Perić I, Jelaković B, Lombard JH, Kunert MP, Kibel A, Gros M. High-Salt Diet and Hypertension: Focus on the Renin-Angiotensin System. Kidney Blood Press Res. 2011;34(1):1–11.

Zhou X, Matavelli L, Frohlich ED. Uric acid: Its relationship to renal hemodynamics and the renal renin-angiotensin system. Curr Hypertens Rep. 2006 Mar 1;8(2):120–4.

Kang H-T, Shim J-Y, Lee Y-J, Lee J-E, Linton JA, Kim J-K, et al. Association between the Ratio of Triglycerides to High-Density Lipoprotein Cholesterol and Chronic Kidney Disease in Korean Adults: The 2005 Korean National Health and Nutrition Examination Survey. Kidney Blood Press Res. 2011;34(3):173–9.

Ritz E, Wanner C. Lipid Changes and Statins in Chronic Renal Insufficiency. J Am Soc Nephrol. 2006 Dec 1;17(12 suppl 3):S226–30.

Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Archives of internal medicine. 2006 Sep 25;166(17):1884-91.

Kim J-Y, Kang H-T, Lee H-R, Lee Y-J, Shim J-Y. Comparison of Lipid-Related Ratios for Prediction of Chronic Kidney Disease Stage 3 or More in Korean Adults. J Korean Med Sci. 2012;27(12):1524.

Johnson ALICM, Stahl A, Zager RA. Triglyceride accumulation in injured renal tubular cells: Alterations in both synthetic and catabolic pathways. Kidney Int. 2005 Jun;67(6):2196–209.

Baragetti A, Norata GD, Sarcina C, Rastelli F, Grigore L, Garlaschelli K, Uboldi P, Baragetti I, Pozzi C, Catapano AL. High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease. Journal of internal medicine. 2013 Sep;274(3):252-62.

Sun K, Lin D, Li F, Huang C, Qi Y, Xue S, Tang J, Yang C, Li Y, Ren M, Yan L. Discordant associations of lipid parameters with albuminuria and chronic kidney disease: a population- based study. Lipids in health and disease. 2015 Dec;14(1):152.

Villabona C, Sahun M, Gómez N, Gómez JM, Soler J, Roca M, et al. Blood Volumes and Renal Function in Overt and Subclinical Primary Hypothyroidism. Am J Med Sci. 1999 Oct 1;318(4):277–80.

Hollander JGD, Wulkan RW, Mantel MJ, Berghout A. Correlation between severity of thyroid dysfunction and renal function. Clin Endocrinol (Oxf). 62(4):423–7.

Zhang Y, Chang Y, Ryu S, Cho J, Lee W-Y, Rhee E-J, et al. Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study. Int J Epidemiol. 2014 Oct 1;43(5):1624–32.

Huang X, Ding L, Peng K, Lin L, Wang T, Zhao Z, Xu Y, Lu J, Chen Y, Wang W, Bi Y. Thyroid hormones associate with risk of incident chronic kidney disease and rapid decline in renal function: a prospective investigation. Journal of translational medicine. 2016 Dec;14(1):336.

Cooper DS, Biondi B. Subclinical thyroid disease. The Lancet. 2012 Mar 24;379(9821):1142–54.

Åsvold BO, Bjøro T, Vatten LJ. Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study. Eur J Endocrinol. 2011 Jan 1;164(1):101–5.

Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Archives of internal medicine. 2000 Feb 28;160(4):526-34

García-Trabanino R, Jarquín E, Wesseling C, Johnson RJ, González-Quiroz M, Weiss I, et al. Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador – A cross- shift study of workers at risk of Mesoamerican nephropathy. Environ Res. 2015 Oct 1;142:746–55.

Soderland P, Lovekar S, Weiner DE, Brooks DR, Kaufman JS. Chronic Kidney Disease Associated With Environmental Toxins and Exposures. Adv Chronic Kidney Dis. 2010 May 1;17(3):254–64.

McClean M, Laws R, Rubio OR, Brooks D, Kaufman J, Weiner D, Nicholson S, Miller A, Makey C, Collins E, Ames J. Industrial hygiene/occupational health assessment: evaluating potential hazards associated with chemicals and work practices at the Ingenio San Antonio (Chichigalpa, Nicaragua). Boston, MA: Boston University School of Public Health. 2010.

Ting SMS, Nair H, Ching I, Taheri S, Dasgupta I. Overweight, Obesity and Chronic Kidney Disease. Nephron Clin Pract. 2009;112(3):c121–7.

Burton JO, Gray LJ, Webb DR, Davies MJ, Khunti K, Crasto W, et al. Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population. Nephrol Dial Transplant. 2012 May 1;27(5):1860–6.

Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk Factors for Chronic Kidney Disease: A Prospective Study of 23,534 Men and Women in Washington County, Maryland. J Am Soc Nephrol. 2003 Nov 1;14(11):2934–41.

Orth SR, Hallan SI. Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients—Absence of Evidence or Evidence of Absence? Clin J Am Soc Nephrol. 2008 Jan 1;3(1):226–36.

Singh NP, Ingle GK, Saini VK, Jami A, Beniwal P, Lal M, Meena GS. Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and Modification of Diet in Renal Disease equation: an observational, cross- sectional study. BMC nephrology. 2009 Dec;10(1):4

Varma PP, Raman DK, Ramakrishnan TS, Singh P, Varma A. Prevalence of early stages of chronic kidney disease in apparently healthy central government employees in India. Nephrol Dial Transplant. 2010 Sep;25(9):3011–7.

235. Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant. 2005 Aug 1;20(8):1638–42.

Vassalotti JA, Li S, Chen S-C, Collins AJ. Screening Populations at Increased Risk of CKD: The Kidney Early Evaluation Program (KEEP) and the Public Health Problem. Am J Kidney Dis. 2009 Mar 1;53(3, Supplement 3):S107–14.

Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, et al. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study. Clin Exp Nephrol. 2017 Jun;21(3):446–56.

Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD. Am J Kidney Dis. 2014 May;63(5):713–35.

Ying T, Clayton P, Naresh C, Chadban S. Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression. BMC nephrology. 2018 Dec;19(1):55.

Chang YC, Chang CH, Yeh YC, Chuang LM, Tu YK. Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study. Scientific reports. 2018 Feb 1;8(1):2031.

Khatiwada S, Rajendra KC, Gautam S, Lamsal M, Baral N. Thyroid dysfunction and dyslipidemia in chronic kidney disease patients. BMC Endocrine disorders. 2015 Dec;15(1):65

Haro JM, Sabio JM, Vargas F. Renal β-adrenoceptors in thyroxine-treated rats. J Endocrinol Invest. 1992 Sep 1;15(8):605–8.

Vargas F, Moreno JM, Rodríguez-Gómez I, Wangensteen R, Osuna A, Álvarez-Guerra M, et al. Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol. 2006 Feb 1;154(2):197–212.

Yuan Z, Zhao M, Zhang B, Zhang H, Zhang X, Guan Q, Ning G, Gao L, Xue F, Zhao J. Thyroid function modifies the association between ratio of triglyceride to high-density lipoprotein cholesterol and renal function: a multicenter cross-sectional study. Scientific reports. 2015 Jul 16;5:11052.

Zaman SB, Hossain N, Rahman M. Associations between Body Mass Index and Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients: Findings from the Northeast of Thailand. :9.

Aryee C, Owiredu WK, Osei-Yeboah J, Owusu-Dabo E, Laing EF, Owusu IK. An Analysis of Anthropometric Indicators and Modifiable Lifestyle Parameters Associated with Hypertensive Nephropathy. International journal of hypertension. 2016;2016.

Jaroszynski A, Dereziński T, Jaroszyńska A, Zapolski T, Wąsikowska B, Wysokiński A, et al. Association of anthropometric measures of obesity and chronic kidney disease in elderly women. Ann Agric Environ Med. 2016 Sep 27;23(4):636–40.

Hall JE. Mechanisms of Abnormal Renal Sodium Handling in Obesity Hypertension. 2018;7.

Sharma M, Doley P, Das HJ. Etiological profile of chronic kidney disease: A single-center retrospective hospital-based study. Saudi J Kidney Dis Transplant. 2018 Mar 1;29(2):409.

Soman SK, Areekal B, Varghese RG, John S, Gopan RS, Jacob QM, et al. Chronic kidney disease-prevalence and determinants among type 2 diabetes mellitus patients attending a primary care setting in central Kerala. Int J Community Med Public Health. 2018 Jun 22;5(7):2776–81.

Wu B, Bell K, Stanford A, Kern DM, Tunceli O, Vupputuri S, et al. Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012. BMJ Open Diabetes Res Care. 2016 Apr;4(1):e000154.

Gatwood J, Chisholm-Burns M, Davis R, Thomas F, Potukuchi P, Hung A, et al. Evidence of chronic kidney disease in veterans with incident diabetes mellitus. Reboldi G, editor. PLOS ONE. 2018 Feb 9;13(2):e0192712.

Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, et al. Renal Function and Intensive Lowering of Blood Pressure in Hypertensive Participants of the Hypertension Optimal Treatment (HOT) Study. J Am Soc Nephrol. 2001 Feb 1;12(2):218–25.

Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S, for the HOPE Investigators. Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial. Ann Intern Med. 2001 Apr 17;134(8):629.

Culleton BF, Larson MG, Wilson PWF, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999 Dec;56(6):2214–9.